cerium has been researched along with Colitis Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asgharzadeh, F; Avan, A; Hashemzadeh, A; Khazaei, M; Mehr, SMH; Nazari, SE; Rahmani, F; Soleimanpour, S; Yaghoubi, A | 1 |
1 other study(ies) available for cerium and Colitis Gravis
| Article | Year |
|---|---|
Cerium oxide nanoparticles acts as a novel therapeutic agent for ulcerative colitis through anti-oxidative mechanism.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cerium; Colitis, Ulcerative; Colon; Dextran Sulfate; Free Radical Scavengers; Free Radicals; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Nanomedicine; Oxidative Stress; Spectroscopy, Fourier Transform Infrared; Sulfasalazine; Superoxide Dismutase; X-Ray Diffraction | 2021 |